PI3K/AKT/mTOR signaling pathway dysregulation has been reported to affect gastric cancer prognosis and metastasis through epigenetic alterations, such as DNA methylation and histone modifications (Fattahi et al., 2020). The gene discussed is MTOR; the disease is gastric cancer.